穆尔斯拉生物加入欧洲联盟,以推进和商业化细胞外囊泡科学. Mursla Bio joins European consortium to advance and commercialize extracellular vesicle science.

Mursla Bio是外细胞血管(EV)研究的领头人,它加入了EverEST,这是一个旨在推进EV科学及其临床应用的欧洲联合会。 Mursla Bio, a leader in Extracellular Vesicle (EV) research, has joined EVEREST, a European consortium aiming to advance EV science and its clinical applications. 该项目涉及11个国家的22个机构和80多名Marie Curie研究员,由欧洲联盟提供资金,都柏林大学学院负责协调。 The project, involving 22 institutions and over 80 Marie Curie fellows across 11 countries, is funded by the European Union and coordinated by University College Dublin. Mursla Bio将侧重于扩大EV产品的规模并使其商业化,特别是用于临床诊断。 Mursla Bio will focus on scaling and commercializing EV products, especially for clinical diagnostics.